{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:13:04Z","timestamp":1720746784785},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000},"content-version":"vor","delay-in-days":168,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/j.ebcr.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T20:45:47Z","timestamp":1439325947000},"page":"63-66","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy"],"prefix":"10.1016","volume":"4","author":[{"given":"James W.","family":"Wheless","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9639","key":"10.1016\/j.ebcr.2015.06.008_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0010","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s11940-013-0249-2","article-title":"Management of CNS-related disease manifestations in patients with tuberous sclerosis complex","volume":"15","author":"Krueger","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0015","first-page":"2021","article-title":"Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options","volume":"10","author":"Wang","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1528-1157.2001.042007935.x","article-title":"Lamotrigine therapy of epilepsy in tuberous sclerosis","volume":"42","author":"Franz","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0030","first-page":"87","article-title":"Topiramate as therapy for tuberous sclerosis","volume":"41","author":"Franz","year":"2000","journal-title":"Epilepsia"},{"issue":"suppl 9","key":"10.1016\/j.ebcr.2015.06.008_bb0035","first-page":"134","article-title":"The role of levetiracetam in pediatric epilepsy","volume":"44","author":"Huerter","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/08830738040190090801","article-title":"Managing epilepsy in tuberous sclerosis complex","volume":"19","author":"Thiele","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0045","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2013.05.029","article-title":"Role of the mTOR signaling pathway in epilepsy","volume":"332","author":"Meng","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12035-012-8314-5","article-title":"The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis","volume":"46","author":"Russo","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/ern.13.48","article-title":"A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials","volume":"13","author":"Wong","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0404.2010.01442.x","article-title":"Prevalence of Parkinson's disease and atypical parkinsonian syndromes in a rural Japanese district","volume":"124","author":"Osaki","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0070","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0080","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0085","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jpeds.2013.12.053","article-title":"Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex","volume":"164","author":"Cardamone","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejpn.2013.06.002","article-title":"Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?","volume":"17","author":"Wiegand","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejpn.2013.03.002","article-title":"Long-term effect of everolimus on epilepsy and growth in children under 3years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"17","author":"Kotulska","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0100","series-title":"Afinitor Disperz (everolimus tablets for oral suspension) [prescribing information]","article-title":"Afinitor (everolimus tablets for oral administration)","author":"Novartis Pharmaceuticals Corporation","year":"2014"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1528-1167.2011.03118.x","article-title":"Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers","volume":"52","author":"Bullman","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182815428","article-title":"Everolimus long-term safety and efficacy in subependymal giant-cell astrocytoma","volume":"80","author":"Krueger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0125","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0130","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2012-3607","article-title":"Possible prevention of tuberous sclerosis complex lesions","volume":"132","author":"Kotulska","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0135","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1542\/peds.2010-2910","article-title":"Regression of a cardiac rhabdomyoma in a patient receiving everolimus","volume":"127","author":"Tiberio","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0140","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1097\/MPH.0000000000000005","article-title":"Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus","volume":"36","author":"Aguilera","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ebcr.2015.06.008_bb0145","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00381-013-2170-0","article-title":"Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex","volume":"29","author":"Cappellano","year":"2013","journal-title":"Childs Nerv Syst"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323215000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323215000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T04:26:01Z","timestamp":1537417561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323215000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":29,"alternative-id":["S2213323215000274"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2015.06.008","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2015.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}